SCHEMBL7224863

SCHEMBL7224863

O=C(O)[C@H](Cc1ccc(OC(=O)N2CCSCC2)cc1)NC(=O)[C@H]1CCCC[C@@H]1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 5/20 0.47
ITGA4 P13612 4/20 0.47
ITGB7 P26010 4/20 0.47
POLB P06746 2/20 0.45
YAP1 P46937 2/20 0.42
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ITGB3 P05106 2/20 0.41
ITGAV P06756 1/20 0.41
ITGA5 P08648 1/20 0.41
MAPK1 P28482 1/20 0.40
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ADORA2A P29274 1/20 0.39
ITGA2B P08514 1/20 0.39
MME P08473 1/20 0.38
ACE P12821 1/20 0.38
CPA1 P15085 1/20 0.38
ACE2 Q9BYF1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7230074 0.89 ITGB1 (0.48) ITGB1ITGA4ITGB7POLBYAP1
SCHEMBL6568912 0.81 ITGB1 (0.51) ITGB1ITGA4ITGB7ALDH1A1HSD17B10
SCHEMBL6568334 0.74 ITGB1 (0.49) ITGB1ITGA4ITGB3ITGAVITGA5
SCHEMBL6569673 0.73 ITGB1 (0.52) ITGB1ITGA4ITGB3ITGAVITGA5
SCHEMBL5608959 0.73 ITGB1 (0.54) ITGB1ITGA4ITGB7ALDH1A1L3MBTL1
SCHEMBL4423030 0.73 ITGA4 (0.58) ITGB1ITGA4ITGB7ALDH1A1ITGAV
SCHEMBL3850695 0.73 ITGA4 (0.58) ITGB1ITGA4ITGB7ALDH1A1ITGAV
SCHEMBL3858016 0.72 ITGB1 (0.54) ITGB1ITGA4ITGB7ALDH1A1ITGB3
SCHEMBL6568226 0.71 ITGB1 (0.44) ITGB1ITGA4ITGB7ITGB3ITGAV
SCHEMBL6568926 0.71 ITGB1 (0.44) ITGB1ITGA4ITGB7ITGB3ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545160-B2 Alpha-aminoacetic acid derivatives bind alpha 4 beta 7 integrin, useful for treatment of inflammatory diseases in mammalian patient, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, rheumatoid arthritis ELAN PHARMACEUTICALS, INC. 2003-04-08 US disclosed
EP-1161416-A1 ALPHA-AMINOACETIC ACID DERIVATIVES USEFUL AS ALPHA 4 BETA 7 - RECEPTOR ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2001-12-12 EP disclosed
WO-2000051974-A1 ALPHA-AMINOACETIC ACID DERIVATIVES USEFUL AS ALPHA 4 BETA 7 - RECEPTOR ANTAGONISTS ELAN PHARMACEUTICALS, INC. (US) 2000-09-08 WO disclosed